跳至主要内容
临床试验/NCT05063032
NCT05063032招募中不适用

Left Atrial FLUTter: a Comparison of Ablation Guided by High-density MApping and Empirical LINEar Ablation - the FLUTMALINE Trial

Hospital Universitario La Paz1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年1月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Proportion of patients without sustained (≥30 s) atrial arrhythmia episodes over 1-year follow-up in each group.

研究概览

简要总结

Unicenter, 1:1 randomized, open-labelled clinical trial comparing left atrial flutter ablation using high density mapping or strict lineal ablation. Main outcome: arrhythmia recurrences over 1 year follow-up with daily 1-lead 30 seconds ECG samples.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Left atrial flutter1 inducible during electrophysiological evaluation.
  • •Clinical indication for ablation: a) symptoms (palpitations, dizziness, syncope, breathlessness, derangement, heart failure), tachymiopathy, b) poor heart rate control, or c) recurrence after electrical cardioversion or failure of one antiarrhythmic drug.
  • •Informed consent.
  • •Patients will be enrolled if LAFL is clinically suspected but finally randomized if this mechanism is established by electrophysiologic evaluation according to the criteria stated above.

排除标准

  • •Previous ablation of LAFL.
  • •Previous linear ablation in the LA except for pulmonary vein isolation.
  • •Absolute contraindication for oral anticoagulation.
  • •Stroke or acute coronary syndrome less than 3 months before ablation.
  • •Complex congenital heart disease.

研究组 & 干预措施

High-density mapping guided ablation

Experimental

High-density map and return-cycles map in order to localize the protected isthmus with precision for focal/minimal ablation.

干预措施: Radiofrecuency ablation (Other)

Empirical linear ablation

Active Comparator

Empirical predefined set of linear ablation.

干预措施: Radiofrecuency ablation (Other)

结局指标

主要结局

Proportion of patients without sustained (≥30 s) atrial arrhythmia episodes over 1-year follow-up in each group.

时间窗: 1 year follow-up

Daily 1-lead 30 seconds ECG samples.

次要结局

  • Safety.(Acute a 1 month after ablation (procedure-related complications).)
  • Acute success.(Acute intraprocedural.)
  • Non-inducibility.(Acute intraprocedural.)
  • Hospitalization.(1 year.)
  • Procedure duration.(Acute intraprocedural.)
  • Left atrial dwell time.(Acute intraprocedural.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Sergio Castrejón-Castrejón

Electrophysiologist, Principal investigator (togheter with Dr. José Luis Merino)

Hospital Universitario La Paz

研究点 (1)

Loading locations...

相似试验